BEIJING, Dec. 8, 2025 -- A report from China Daily: With 2026 marking the start of the 15th Five-Year Plan (2026-30), it is crucial to further build a unified domestic market and boost domestic consumption. This necessitates creating an even better business environment, with the rule of law remaining a cornerstone for ensuring such an environment. China's top leaders have emphasized that rule of law constitutes the most sound business environment. This guiding remark underscores the intrinsic link between the rule of law and economic development, embodying the fundamental
Partnership Plans to leverage the 2026 Tour now open for Americas, Europe, Middle East & Africa, India and World Editions of summit SINGAPORE, NEW YORK and LONDON, Dec. 8, 2025 -- House of Rose Professional today announced the opening of plans for the 2026 World Tour of Break the ceiling touch the sky® - the success and leadership summit for all (especially executive women and male allies). In 2026, the summit expands its global footprint with editions across the Americas, Asia, the Middle East & Africa, Europe, and ANZ bringing together CEOs, C-suite executives,
SINGAPORE, Dec. 8, 2025 -- BeLive Studios, NewUnivers and ChopChop Systems executed a Memorandum of Understanding (MOU) at the Asia TV Forum and Market (ATF) today. The MOU establishes a strategic framework for collaboration among the three parties in the production, co-production and operational integration of microdrama content. The partnership was initiated through Content IP Xcelerate in Singapore, operated by the Korea Creative Content Agency (KOCCA) Singapore Business Centre, and formally presented during KOCCA's participation at ATF. The signing ceremony was conducted in
SHANGHAI, Dec. 8, 2025 -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from its allogeneic BCMA-targeted CAR T-cell product candidate, CT0596, for the treatment of relapsed/refractory multiple myeloma (R/R MM) was presented in a poster at the 67th American Society of Hematology (ASH) Annual Meeting. The poster was titled "A First-in-Human Study of CT0596, an Allogeneic CAR T-Cell Therapy Targeting BCMA, in Patients with Relapsed/Refractory Multiple Myeloma." The publ
SINGAPORE, Dec. 8, 2025 -- Traveloka, Southeast Asia's leading travel platform, and the Singapore Tourism Board (STB) strengthen their partnership with the launch of a new regional marketing campaign targeting young travellers titled 'A World of Experiences Await'. The initiative aims to position Singapore as a preferred short-haul destination for travellers and repeat visitors seeking spontaneous and convenient getaways from key Southeast Asian markets. When travelling, making the most out of every moment with loved ones is essential. In Singapore, this is made remarka
NANJING, China, Dec. 8, 2025 -- From December 6 to 9, 2025, the 67th Annual Meeting of the American Society of Hematology ("ASH") was held in Orlando, Florida, USA. Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company", Stock Code: 9887.HK) delivered an oral presentation on the opening day of the conference featuring the Phase I/II clinical results of LBL-034, a GPRC5D/CD3 bispecific antibody with a unique 2:1 structure and conditional activation, independently developed using the proprietary LeadsBody platform, for the treatment of relapsed/refractor
SHANGHAI and NANJING, China and PLEASANTON, Calif., Dec. 8, 2025 -- IASO Biotechnology ("IASO Bio"), a commercial-stage biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of novel cell therapies and biologics for hematologic malignancies and autoimmune diseases, announced the oral presentation of updated clinical data for its independently developed, fully human BCMA-targeted CAR-T cell therapy product, Equecabtagene Autoleucel (Eque-cel), for the treatment of transplant-ineligible patients with high-risk newly diagnosed multiple my
SAN FRANCISCO and SUZHOU, China, Dec. 8, 2025 -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major disease areas, announced the initial data of the first-in-human trial of IBI3003, a novel trispecific antibody targeting G protein-coupled receptor C5D (GPRC5D), B-cell maturation antigen (BCMA), and CD3 for the treatment of relapsed or refractory multiple myeloma (R/R MM)
SINGAPORE, Dec. 8, 2025 -- The Dulwich College Ranjit Murugason Sustainability Fund is pleased to announce renewed support from LGT Bank Singapore ("LGT"), reinforcing a three-year collaboration that has helped Dulwich College (Singapore) students develop the skills, confidence and guidance needed to deliver meaningful sustainability and community projects across Singapore and the region. The Sustainability Fund sits at the heart of the College's Live Worldwise vision and Guiding Statements, encouraging students to take purposeful action and thoughtfully engage with issues of
SINGAPORE, Dec. 8, 2025 -- TenPay Global, Tencent's cross-border payment platform, and Mastercard Move, Mastercard's money movement business, have announced a collaboration to facilitate fast, secure and transparent digital remittances directly to Weixin Pay, a leading mobile payment service within the Weixin ecosystem in China. Through Mastercard Move, Mastercard's portfolio of money movement capabilities, eligible senders around the world will be able to send salaries and family support directly to Weixin Pay Wallet Balance or linked bank cards in Weixin Pay. According to the